Literature DB >> 8418227

Body-composition changes in patients who gain weight while receiving megestrol acetate.

C L Loprinzi1, D J Schaid, A M Dose, N L Burnham, M D Jensen.   

Abstract

PURPOSE: Randomized placebo-controlled clinical trials have now established that megestrol acetate causes appetite stimulation and weight gain in patients with anorexia and/or cachexia. There is a paucity of available data to delineate the substance of this increased weight. PATIENTS AND METHODS: Using dual-energy x-ray absorptiometry and tritiated body water methodologies, we performed body-composition measurements in 12 patients with advanced cancer before the institution of oral megestrol acetate (800 mg/d) and at subsequent 2-month intervals.
RESULTS: Seven of the 12 patients gained weight (2.1 to 16.5 kg) and had repeat body-composition measurements performed at the time of maximum weight gain. The vast majority of the gained weight was clearly from an increase in adipose tissue, while there was a suggestion that an increase in body fluid was responsible for a minority of the weight gain.
CONCLUSION: Megestrol acetate-induced weight gain is primarily the result of an increase in body mass.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418227     DOI: 10.1200/JCO.1993.11.1.152

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  39 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 2.  A review of the drug treatment of cachexia associated with cancer.

Authors:  B Gagnon; E Bruera
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 3.  Energy homeostasis and cachexia in chronic kidney disease.

Authors:  Robert H Mak; Wai Cheung
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

Review 4.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

5.  Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.

Authors:  Scott Shadfar; Marion E Couch; Kibwei A McKinney; Lisa J Weinstein; Xiaoying Yin; Jessica E Rodríguez; Denis C Guttridge; Monte Willis
Journal:  Nutr Cancer       Date:  2011-06-09       Impact factor: 2.900

6.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

7.  Residual Ca2+ channel current modulation by megestrol acetate via a G-protein alpha s-subunit in rat hypothalamic neurones.

Authors:  A M Costa; K T Spence; C R Plata-Salamán; J M ffrench-Mullen
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

8.  In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.

Authors:  Kamran A Mirza; Menghua Luo; Suzette Pereira; Anne Voss; Tapas Das; Michael J Tisdale
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-05-18       Impact factor: 2.416

9.  A structured exercise program for patients with advanced non-small cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Sarah Goldberg; Paula Downes Vogel; Michael Sullivan; William F Pirl; Thomas J Lynch; David C Christiani; Matthew R Smith
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

10.  Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.

Authors:  S-S Yeh; S Lovitt; M W Schuster
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.